2007Journal of Internal Intensive MedicineRequires access

Analysis of Drug Resistance on Clinical Isolates of Pseudomonas Aeruginosa

Chen Anqun

Open publisher page 0 citations

Abstract

Objective:To investigate characteristics of drug resistance of clinical pseudomonas aeruginosa isolates,and offer reasonable experimental data for clinical therapy.Methods:Profile of clinical isolates and drug resistance of pseudomonas aeruginosa in recent 3 years were analyzed retrospectively.Results:Among the gram-negative bacilli,isolate rate of pseudomonas aeruginosa was 21%.Results of drug susceptibility showed that the resistante rate of pseudomonas aeruginosa to carbapenem and β-lactamases antibiotics inhibitor was increased(20%),and pseudomonas aeruginosa had a higher susceptibility rate to ceftazidime(82.1%) and amikacin(76.4%).Conclusion:Clinical isolates of pseudomonas aeruginosa have a higher resistante rate.More attentions should be paid to the rational use of antibiotics and the surveillance of antimicrobial resistance.

About this research paper

What this paper is about

Objective:To investigate characteristics of drug resistance of clinical pseudomonas aeruginosa isolates,and offer reasonable experimental data for clinical therapy.Methods:Profile of clinical isolates and drug resistance of pseudomonas aeruginosa in recent 3 years were analyzed retrospectively.Results:Among the gram-negative bacilli,isolate rate of pseudomonas aeruginosa was 21%.Results of drug susceptibility showed that the resistante rate of pseudomonas aeruginosa to carbapenem and β-lactamases antibiotics inhibitor was increased(20%),and pseudomonas aeruginosa had a higher susceptibility rate to ceftazidime(82.1%) and amikacin(76.4%).Conclusion:Clinical isolates of pseudomonas aeruginosa have a higher resistante rate.More attentions should be paid to the rational use of antibiotics and the surveillance of antimicrobial resistance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate characteristics of drug resistance of clinical pseudomonas aeruginosa isolates,and offer reasonable experimental data for clinical therapy.Methods:Profile of clinical isolates and drug resistance of pseudomonas aeruginosa in recent 3 years were analyzed retrospectively.Results:Among the gram-negative bacilli,isolate rate of pseudomonas aeruginosa was 21%.Results of drug susceptibility showed that the resistante rate of pseudomonas aeruginosa to carbapenem and β-lactamases antibiotics inhibitor was increased(20%),and pseudomonas aeruginosa had a higher susceptibility rate to ceftazidime(82.1%) and amikacin(76.4%).Conclusion:Clinical isolates of pseudomonas aeruginosa have a higher resistante rate.More attentions should be paid to the rational use of antibiotics and the surveillance of antimicrobial resistance.

Key concepts: Pseudomonas aeruginosa, Amikacin, Ceftazidime, Microbiology, Medicine, Drug resistance, Antibiotics, Bacilli

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of Drug Resistance on Clinical Isolates of Pseudomonas Aeruginosa — Research Paper | ScholarLens